Glasgow, Scotland-based Novosound develops proprietary flexible thin-film ultrasound technology for medical imaging. The venture-backed company currently targets next-generation intravascular ultrasound (IVUS) imaging.
The startup entered into a wearable ultrasound collaboration with Dr. Todd K. Rosengart, a leading U.S. cardiovascular surgeon. Rosengart serves as VP and DeBakey-Bard chair of surgery at Baylor College of Medicine in Texas.
“I have been very impressed with the Novosound technology and how we are applying it to a global clinical need, which we believe will save lives and could indeed become the next vital sign monitor,” Rosengart said in a news release.
Novosound CEO Dr. Dave Hughes said the company continues to make “remarkable progress” in the U.S. He says it ventured into va…